JACC: Heart Failure

Aims & Scope

JACC: Heart Failure is one of a family of specialist journals launched by the renowned Journal of the American College of Cardiology (JACC).

It publishes the most important findings on the pathophysiology, diagnosis, treatment, and care of heart failure patients.

The goal of the Journal is to improve our understanding of the disease, clinical trial, clinical outcomes, and advances in therapies through timely, insightful scientific communication.

The Journal embraces interdisciplinary relationships with neuroscience, pulmonary medicine, nephrology, electrophysiology, and surgery as they relate to heart failure.

In addition, the Journal includes articles concerning pharmacogenetics, biomarkers, and metabolomics.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	11.8
2024	10.30

Journal Rank

Year	Value
2024	275

Journal Citation Indicator

Year	Value
2024	2699

SJR (SCImago Journal Rank)

Year	Value
2024	5.218

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	118

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Heart Failure

  Citation: 621

  Authors: Eugene

• Impact of Obesity and the Obesity Paradox on Prevalence and Prognosis in Heart Failure

  Citation: 462

  Authors: Carl J., Martin A., Ross, Mandeep R., Richard V., Hector O.

• Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction

  Citation: 443

  Authors: Constantijn, Sophia, Andreas, H. Ibrahim, Gilles W., Carsten, Adelino F., René, Hans W.M., Wolfgang A., Walter J., Nazha

• Temporal Trends in the Incidence of and Mortality Associated With Heart Failure With Preserved and Reduced Ejection Fraction

  Citation: 427

  Authors: Connie W., Asya, Danielle, Martin G., Jennifer E., Jorge R., John S., Bruce M., Ramachandran S.

• The Transition From Hypertension to Heart Failure

  Citation: 403

  Authors: Franz H., Stefano F., Sripal

• The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF

  Citation: 370

  Authors: Nazir, Wouter C., Traci M., Vijeta, Mary, Matthew, Jorge R., Amy, Michael J., Ron T., Julius M., Hans L., Fei, Willem J., Emily S., Douglas S., Ruslan, Wiek H., Thomas J., Markella V., Ramachandran S., Norrina B., Bruce M., Pim, Daniel, Martin, Sanjiv J., Rudolf A., John S., Jennifer E.

• The Effect of Coenzyme Q 10 on Morbidity and Mortality in Chronic Heart Failure

  Citation: 352

  Authors: Svend A., Franklin, Adarsh, Peter, Krzysztof J., Daniel, Urban, Günter, Gian P.

• Pathogenic Gut Flora in Patients With Chronic Heart Failure

  Citation: 341

  Authors: Evasio, Roberto, Cristian, Paola, Stefania, Federica, Manuela, Francesco

• Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure

  Citation: 339

  Authors: Kevin, Mauro, Brian, Pardeep S., Michele, Martin P., Margaret F., Victor C., Jean L., Karl, Michael R., Milton, Akshay S., Scott D., John J.V.

• Left Ventricular Amyloid Deposition in Patients With Heart Failure and Preserved Ejection Fraction

  Citation: 332

  Authors: Selma F., Sultan A., William D., Ahmet, Donna R., Shannon M., Veronique L., Morie A., Angela, Steven R., Margaret M.

---